Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,971 Cr
down ₹143 Cr vs Dec 2025
- Stocks held
- 30
- down 1 vs Dec 2025
- Top 10 weight
- 64.5%
- of the portfolio in its ten largest
- Cash & debt
- 1.2%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 9, trimmed 21
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2026 it disclosed 30 stocks worth ₹2,971 Cr, down ₹143 Cr from Dec 2025. Its largest positions were IPCA Laboratories Limited (8.4%), Sun Pharmaceutical Industries Limited (8.2%), Cipla Limited (8.1%); the ten largest together made up 64.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 62.5% of its equity. Cash and debt stood at 1.2%. Compared with Dec 2025 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
15%
Holds more cash than 15% of peers
Holdings in January 2026
Download CSVEvery line the fund disclosed, with the change against Dec 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.40%
- Δ weight
- up 0.67 pts
- Value
- ₹250 Cr
- Δ value
- up ₹8.8 Cr
- Status
- Added
- Weight
- 8.25%
- Δ weight
- down 0.23 pts
- Value
- ₹245 Cr
- Δ value
- down ₹19.1 Cr
- Status
- Trimmed
- Weight
- 8.08%
- Δ weight
- down 0.61 pts
- Value
- ₹240 Cr
- Δ value
- down ₹30.5 Cr
- Status
- Trimmed
- Weight
- 7.54%
- Δ weight
- up 0.76 pts
- Value
- ₹224 Cr
- Δ value
- up ₹13 Cr
- Status
- Added
- Weight
- 7.18%
- Δ weight
- up 1.11 pts
- Value
- ₹213 Cr
- Δ value
- up ₹24.3 Cr
- Status
- Added
- Weight
- 5.95%
- Δ weight
- down 0.57 pts
- Value
- ₹177 Cr
- Δ value
- down ₹26.2 Cr
- Status
- Trimmed
- Weight
- 5.72%
- Δ weight
- up 0.63 pts
- Value
- ₹170 Cr
- Δ value
- up ₹11.5 Cr
- Status
- Added
- Weight
- 5.04%
- Δ weight
- down 0.19 pts
- Value
- ₹150 Cr
- Δ value
- down ₹13.1 Cr
- Status
- Trimmed
- Weight
- 4.56%
- Δ weight
- up 0.16 pts
- Value
- ₹136 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 3.81%
- Δ weight
- down 1.22 pts
- Value
- ₹113 Cr
- Δ value
- down ₹43.5 Cr
- Status
- Trimmed
- Weight
- 3.76%
- Δ weight
- down 0.12 pts
- Value
- ₹112 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 3.08%
- Δ weight
- down 0.13 pts
- Value
- ₹91.6 Cr
- Δ value
- down ₹8.5 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- down 0.17 pts
- Value
- ₹89.7 Cr
- Δ value
- down ₹9.6 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- down 0.03 pts
- Value
- ₹89.6 Cr
- Δ value
- down ₹5.4 Cr
- Status
- Trimmed
- Weight
- 2.93%
- Δ weight
- down 0.14 pts
- Value
- ₹87 Cr
- Δ value
- down ₹8.6 Cr
- Status
- Trimmed
- Weight
- 2.84%
- Δ weight
- down 0.07 pts
- Value
- ₹84.5 Cr
- Δ value
- down ₹6.4 Cr
- Status
- Trimmed
- Weight
- 2.37%
- Δ weight
- down 0.07 pts
- Value
- ₹70.3 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- down 0.18 pts
- Value
- ₹57.6 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 1.91%
- Δ weight
- up 0.21 pts
- Value
- ₹56.8 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 1.47%
- Δ weight
- down 0.05 pts
- Value
- ₹43.8 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.17%
- Δ weight
- up 0.15 pts
- Value
- ₹34.8 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 1.13%
- Δ weight
- up 0.17 pts
- Value
- ₹33.5 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- down 0.03 pts
- Value
- ₹32.5 Cr
- Δ value
- down ₹2.6 Cr
- Status
- Trimmed
- Weight
- 1.07%
- Δ weight
- down 0.14 pts
- Value
- ₹31.9 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 1.07%
- Δ weight
- down 0.07 pts
- Value
- ₹31.7 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.90%
- Δ weight
- up 0.10 pts
- Value
- ₹26.8 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 0.71%
- Δ weight
- up 0.05 pts
- Value
- ₹21.2 Cr
- Δ value
- up ₹64 L
- Status
- Added
- Weight
- 0.58%
- Δ weight
- up 0.06 pts
- Value
- ₹17.3 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.52%
- Δ weight
- up 0.02 pts
- Value
- ₹15.3 Cr
- Δ value
- down ₹16 L
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up 0.01 pts
- Value
- ₹12.7 Cr
- Δ value
- down ₹40 L
- Status
- Trimmed
- Weight
- 0.26%
- Δ weight
- up 0.05 pts
- Value
- ₹7.9 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.18%
- Δ weight
- down 0.07 pts
- Value
- ₹5.3 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
What changed, Dec 2025 to Jan 2026
New New positions (0)
None.
Exited Exited (1)
- Thyrocare Technologies Limitedwas 0.1% · ₹1.9 Cr
Added Biggest additions
- Illumina Incup ₹24.3 Cr (+1.11% pts)
- Globus Medical Incup ₹13 Cr (+0.76% pts)
- Gland Pharma Limitedup ₹11.5 Cr (+0.63% pts)
- IPCA Laboratories Limitedup ₹8.8 Cr (+0.67% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2025, the weight rose most in Healthcare Services (+1.3 pts) and Healthcare Equipment & Supplies (+0.6 pts), and fell most in Pharmaceuticals & Biotechnology (−1.6 pts) and Pharmaceuticals (−0.3 pts).
- Healthcare Services18.7% → 20.0%+1.3 pts
- Healthcare Equipment & Supplies10.3% → 10.9%+0.6 pts
- Pharmaceuticals & Biotechnology64.1% → 62.5%−1.6 pts
- Pharmaceuticals4.9% → 4.6%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2023 | Jan 2025 | Jul 2025 | Oct 2025 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 67.6% | 63.7% | 67.5% | 66.2% | 64.1% | 62.5% |
| Healthcare Services | 16.6% | 18.9% | 17.4% | 18.6% | 18.7% | 20.0% |
| Healthcare Equipment & Supplies | 6.6% | 10.2% | 6.9% | 7.9% | 10.3% | 10.9% |
| Pharmaceuticals | 5.8% | 5.3% | 6.1% | 5.4% | 4.9% | 4.6% |
| Insurance | 2.3% | 1.4% | 1.5% | 1.6% | 1.5% | 1.5% |
| Retailing | 1.0% | 0.4% | 0.6% | 0.5% | 0.5% | 0.5% |
Allocation in Jan 2026change vs Dec 2025
- Pharmaceuticals & Biotechnology (15)62.5%▼ 1.6 pts
- Healthcare Services (7)20.0%▲ 1.3 pts
- Healthcare Equipment & Supplies (3)10.9%▲ 0.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jan 2026
1.2%
▲ 0.1 pts vs Dec 2025
- Cash alone
- 1.2%
- cash and net receivables
- A year earlier
- 0.8%
- Jan 2025 · now ▲ 0.4 pts
- Last 12 months
- 0.1% – 2.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.